Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul Caldwell

Sports Medicine Richmond, VA Medical Doctor

NPI 1457304784 CMS profile 201306

1501 Maple Ave, Nw Mob Suite 200, Richmond, VA 23226

Open in the dashboard

General payments

$146,708

347 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paul Caldwell of Richmond, VA is reported in the CMS Open Payments database as having received $146,708 across 347 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $27,348 29
2024 General $12,952 54
2023 General $17,526 63
2022 General $20,534 50
2021 General $44,472 70
2020 General $13,339 40
2019 General $10,537 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Caldwell
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Paul Caldwell were reported at $27,348. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Paul Caldwell Sports Medicine median Middle half National median
2019 $10,537 $1,176 $199–$4,249 $163
2020 $13,339 $708 $96–$2,890 $114
2021 $44,472 $1,213 $152–$3,994 $132
2022 $20,534 $1,230 $159–$3,998 $149
2023 $17,526 $584 $146–$2,836 $160
2024 $12,952 $628 $163–$3,168 $164
2025 $27,348 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $118,982 202 payments
  2. Joint Restoration Foundation, Inc. $12,100 4 payments
  3. Vericel Corporation $7,480 9 payments
  4. Fortis Surgical, LLC $6,053 56 payments
  5. Geistlich Pharma, North America, Inc. $750 1 payment
  6. Horizon Therapeutics plc $613 55 payments
  7. Aesculap Biologics, LLC $287 3 payments
  8. DePuy Synthes Sales Inc. $151 6 payments
  9. Linvatec Corporation $80 2 payments
  10. Flexion Therapeutics, Inc. $74 2 payments
  11. Other $139 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $70,942 23 payments
  2. Consulting Fee $48,280 23 payments
  3. Travel and Lodging $17,516 60 payments
  4. Food and Beverage $5,498 238 payments
  5. Education $2,673 2 payments
  6. Honoraria $1,800 1 payment
Products named General payments · program years 2019–2025
  1. BIOLOGICS CONSUMABLES AUTOLOGOUS FAT PRODUCTS ADIPOSE $7,140 2 payments
  2. MACI Cellular Therapy $5,043 4 payments
  3. MACI Cellular Therapy $2,362 3 payments
  4. NEXO-GIDE $750 1 payment
  5. NOVOCART 3D $287 3 payments
  6. PENNSAID $215 20 payments
  7. DUEXIS $182 16 payments
  8. VIMOVO Vimovo $144 13 payments
  9. VIMOVO Vimovo $144 13 payments
  10. MONOVISC $89 4 payments
  11. Other $719 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

215

Median for Sports Medicine: 144

Drug cost

$1,253

Median for Sports Medicine: $1,027

Branded share of claims

19.5%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 42 $336
Diclofenac Sodium Generic 33 $293
Ibuprofen Generic 23 $287
Methylprednisolone Generic 27 $153
Meloxicam Generic 69 $127
Cyclobenzaprine Hcl Generic 21 $56

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$108,637

Of which drugs: $4,645

Medicare patients

329

Average age 73

Services billed

14,885

198 women, 131 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 67%
Ischemic heart disease 32%
Diabetes 26%
Depression 18%
Atrial fibrillation 15%
Chronic kidney disease 14%
COPD 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 123 13,763 $1,391
Injection, methylprednisolone acetate, 40 mg J1030 Office 46 113 $458

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

347 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record